Genes
NCBI Gene
One gene with its proteins, patents, drugs, trials, grants and papers.
85,013 comparisons from ClinicalTrials.gov. Counted 2026-11-10.
Most participants first33,758 with no events in either group come last101 to 120 of 85,013
| Comparison | With the outcome | Risk difference, 95% interval | Participants | Trial |
|---|---|---|---|---|
| Intervention Health Facility Participants vs Control Health Facility Participants: Count of Participants With Early Neonatal Death | 2,409 of 78,360 2,119 of 75,851 | 0.3 points 0.1 to 0.4 | 154,211 | NCT02148952 BetterBirth: A Trial of the WHO Safe Childbirth Checklist Program |
| Intervention Health Facility Participants vs Control Health Facility Participants: Count of Newborns Returning to Facility for a Health Problem Within 7 Days | 4,474 of 77,419 4,722 of 75,117 | -0.5 points -0.7 to -0.3 | 152,536 | NCT02148952 BetterBirth: A Trial of the WHO Safe Childbirth Checklist Program |
| Hp Stool Antigen (HpSA)+FIT vs FIT Only: Participation Rate of HpSA + FIT or FIT Only | 31,497 of 63,508 31,777 of 88,995 | 13.9 points 13.4 to 14.4 | 152,503 | NCT01741363 Screening for Stomach Diseases and Colorectal Neoplasms With the Fecal Testing |
| Vortioxetine Treatment vs SSRI Treatment: Number of Participants Who Experienced of Intracranial Hemorrhage in Total Follow-up Period | 2 of 22,827 25 of 124,950 | -0.0 points -0.0 to 0.0 | 147,777 | NCT05932407 A Database Survey of Comparison The Risk of Haemorrhage Between Vortioxetine Tablet Treatment and Selective Serotonin Reuptake Inhibitor (SSRI) Treatment in Participants With Depression |
| PCV13-vaccinated Participants vs Unvaccinated Participants: VE for First Event of IPD at 3-5 Years of Follow-up | 59 of 47,501 116 of 98,677 | 0.0 points -0.0 to 0.0 | 146,178 | NCT05794191 A Study To Learn About The Effects Of Pneumococcal Vaccine In People With HIV |
| PCV13-vaccinated Participants vs Unvaccinated Participants: VE for First Event of PP at 3-5 Years of Follow-up | 94 of 47,365 184 of 98,430 | 0.0 points -0.0 to 0.1 | 145,795 | NCT05794191 A Study To Learn About The Effects Of Pneumococcal Vaccine In People With HIV |
| PCV13-vaccinated Participants vs Unvaccinated Participants: VE for First Event of ACP at 3-5 Years of Follow-up | 2,079 of 41,296 4,437 of 86,841 | -0.1 points -0.3 to 0.2 | 128,137 | NCT05794191 A Study To Learn About The Effects Of Pneumococcal Vaccine In People With HIV |
| Standard Texts vs Standard Texts With Transportation Messaging: Number of Participants Vaccinated at the End of the Campaign Period | 33,357 of 121,743 854 of 3,050 | -0.6 points -2.2 to 1.0 | 124,793 | NCT05537441 Precision Vaccine Promotion in Underserved Populations |
| ACP Video Program vs Usual ACP Procedures: deaths from any cause | 8,403 of 33,035 17,251 of 70,013 | 0.8 points 0.2 to 1.4 | 103,048 | NCT02612688 Pragmatic Trial of Video Education in Nursing Homes |
| E-MOTIVE Intervention vs Usual Care: Rate of All Cause Neonatal Mortality Postpartum Until Discharge From the Health Facility | 2,259 of 49,923 2,233 of 51,535 | 0.2 points -0.1 to 0.4 | 101,458 | NCT04341662 A Clinical Trial to Study the Effectiveness of a Care Bundle to Prevent Bleeding After a Woman Has Given Birth |
| Intervention Group vs Control Group: serious adverse events | 2,932 of 48,698 2,774 of 52,007 | 0.7 points 0.4 to 1.0 | 100,705 | NCT01084096 Trial of the Use of Antenatal Corticosteroids in Developing Countries |
| E-MOTIVE Intervention vs Usual Care: Postpartum Maternal Death From Bleeding Until Discharge From the Health Facility | 12 of 49,101 18 of 50,558 | -0.0 points -0.0 to 0.0 | 99,659 | NCT04341662 A Clinical Trial to Study the Effectiveness of a Care Bundle to Prevent Bleeding After a Woman Has Given Birth |
| E-MOTIVE Intervention vs Usual Care: Number of Women Receiving Uterine Balloon Tamponade Postpartum Until Discharge From the Health Facility | 44 of 49,101 57 of 50,558 | -0.0 points -0.1 to 0.0 | 99,659 | NCT04341662 A Clinical Trial to Study the Effectiveness of a Care Bundle to Prevent Bleeding After a Woman Has Given Birth |
| E-MOTIVE Intervention vs Usual Care: Number of Women Transferred to a Higher-level Facility Postpartum Until Discharge From the Health Facility | 85 of 49,101 18 of 50,558 | 0.1 points 0.1 to 0.2 | 99,659 | NCT04341662 A Clinical Trial to Study the Effectiveness of a Care Bundle to Prevent Bleeding After a Woman Has Given Birth |
| E-MOTIVE Intervention vs Usual Care: Rate of All Cause Maternal Mortality Postpartum Until Discharge From the Health Facility | 17 of 49,101 28 of 50,558 | -0.0 points -0.0 to 0.0 | 99,659 | NCT04341662 A Clinical Trial to Study the Effectiveness of a Care Bundle to Prevent Bleeding After a Woman Has Given Birth |
| E-MOTIVE Intervention vs Usual Care: Number of Women Receiving Non-pneumatic Anti-shock Garment (NASG) Postpartum Until Discharge From the Health Facility | 90 of 49,101 38 of 50,558 | 0.1 points 0.1 to 0.2 | 99,659 | NCT04341662 A Clinical Trial to Study the Effectiveness of a Care Bundle to Prevent Bleeding After a Woman Has Given Birth |
| E-MOTIVE Intervention vs Usual Care: Number of Women With Laparotomy With Arterial Ligation Postpartum Until Discharge From the Health Facility | 0 of 49,101 2 of 50,558 | -0.0 points -0.0 to 0.0 | 99,659 | NCT04341662 A Clinical Trial to Study the Effectiveness of a Care Bundle to Prevent Bleeding After a Woman Has Given Birth |
| E-MOTIVE Intervention vs Usual Care: PPH Treatment by Healthcare Provider up to 2 Hours Postpartum (or up to 24 Hours if Bleeding Continues) | 5,921 of 49,101 4,899 of 50,558 | 2.4 points 2.0 to 2.8 | 99,659 | NCT04341662 A Clinical Trial to Study the Effectiveness of a Care Bundle to Prevent Bleeding After a Woman Has Given Birth |
| E-MOTIVE Intervention vs Usual Care: Number of Women Receiving a Blood Transfusion Postpartum Until Discharge From the Health Facility | 1,074 of 49,101 1,296 of 50,558 | -0.4 points -0.6 to -0.2 | 99,659 | NCT04341662 A Clinical Trial to Study the Effectiveness of a Care Bundle to Prevent Bleeding After a Woman Has Given Birth |
| E-MOTIVE Intervention vs Usual Care: Number of Women Receiving Blood Transfusion for Postpartum Haemorrhage Until Discharge From the Health Facility | 580 of 49,101 944 of 50,558 | -0.7 points -0.8 to -0.5 | 99,659 | NCT04341662 A Clinical Trial to Study the Effectiveness of a Care Bundle to Prevent Bleeding After a Woman Has Given Birth |
Response
The first 2 of this page's 20 results. GET /api/comparisons/v1?page=6
{
"data": {
"total": 85013,
"results": [
{
"id": "NCT02148952-5e61cf31",
"title": "Intervention Health Facility Participants vs Control Health Facility Participants: Count of Participants With Early Neonatal Death",
"summary": "2409 of 78360 against 2119 of 75851; risk difference 0.3 points, 95% interval 0.1 to 0.4; NCT02148952, BetterBirth: A Trial of the WHO Safe Childbirth Checklist Program",
"record": "/library/comparisons/NCT02148952-5e61cf31",
"nct_id": "NCT02148952",
"kind": "outcome",
"participants": 154211,
"risk_difference": {
"value": 0.0028063769860080523,
"lower": 0.0011215599327533505,
"upper": 0.004490916102906268
},
"group_1": "2,409 of 78,360",
"group_2": "2,119 of 75,851",
"difference": "0.3 points",
"interval": "0.1 to 0.4",
"trial_title": "BetterBirth: A Trial of the WHO Safe Childbirth Checklist Program"
},
{
"id": "NCT02148952-edf23a91",
"title": "Intervention Health Facility Participants vs Control Health Facility Participants: Count of Newborns Returning to Facility for a Health Problem Within 7 Days",
"summary": "4474 of 77419 against 4722 of 75117; risk difference -0.5 points, 95% interval -0.7 to -0.3; NCT02148952, BetterBirth: A Trial of the WHO Safe Childbirth Checklist Program",
"record": "/library/comparisons/NCT02148952-edf23a91",
"nct_id": "NCT02148952",
"kind": "outcome",
"participants": 152536,
"risk_difference": {
"value": -0.0050725038459114025,
"lower": -0.007464479570806629,
"upper": -0.0026828162491589393
},
"group_1": "4,474 of 77,419",
"group_2": "4,722 of 75,117",
"difference": "-0.5 points",
"interval": "-0.7 to -0.3",
"trial_title": "BetterBirth: A Trial of the WHO Safe Childbirth Checklist Program"
}
],
"no_events": 33758,
"columns": [
{
"key": "title",
"label": "Comparison"
},
{
"key": "group_1",
"label": "With the outcome",
"under": "group_2"
},
{
"key": "difference",
"label": "Risk difference, 95% interval",
"under": "interval"
},
{
"key": "participants",
"label": "Participants"
},
{
"key": "nct_id",
"label": "Trial",
"under": "trial_title"
}
],
"order": "Most participants first",
"kinds": {
"all": 85013,
"outcome": 33568,
"serious-adverse-events": 31897,
"deaths": 19548
}
},
"release": "trial-comparisons-2026-03-23-0.1.0",
"terms": [
{
"source": "ClinicalTrials.gov's posted results, through CTTI's AACT",
"license": "ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299",
"notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.",
"short": "Freely available. Acknowledgement requested"
},
{
"source": "ClinicalTrials.gov",
"license": "none stated",
"notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.",
"short": "None stated"
}
],
"next": "/api/comparisons/v1?page=7",
"request_id": "kSQ98BQmuzyvWkRc"
}ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.
NCBI Gene
One gene with its proteins, patents, drugs, trials, grants and papers.
ClinicalTrials.gov
Search clinical trials by condition, drug, outcome or NCT number, with the results each one posted.
Patent publications
Paste a sequence and see the patents that disclose it.
For invited accounts.
Opens sequences.conductscience.org
For software
Every answer on this page is also JSON, under /api/comparisons/v1. No key.
GET https://conductscience.org/api/comparisons/v1?q=placebo%20heart%20failure&kind=outcome
Ask an assistant